Alzheimer Disease Research Center

$2,157,168P50FY2011AGNIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications & trials

Paper 39677464 Paper 39379761 Paper 39375347 Paper 39254167 Paper 39207439 Paper 39173101 Paper 39132765 Paper 38980643 Paper 38958543 Paper 38958117 Paper 38949538 Paper 38883718 Paper 38721926 Paper 38712163 Paper 38641585 Paper 38626853 Paper 38460116 Paper 38441951 Paper 38425303 Paper 38423160 Paper 38418871 Paper 38244935 Paper 38194584 Paper 38077091 Paper 38076972 Paper 38034419 Paper 37708739 Paper 37592813 Paper 37580727 Paper 37528055 Paper 37503159 Paper 37491248 Paper 37474615 Paper 37322115 Paper 37260021 Paper 37245492 Paper 37212114 Paper 37057867 Paper 37051669 Paper 37038809 Paper 36997127 Paper 36970907 Paper 36965457 Paper 36946449 Paper 36840665 Paper 36758620 Paper 36722399 Paper 36710669 Paper 36681388 Paper 36648159 Paper 36628434 Paper 36621368 Paper 36617779 Paper 36577280 Paper 36565204 Paper 36536382 Paper 36530083 Paper 36482861 Paper 36394443 Paper 36324086 Paper 36317464 Paper 36314203 Paper 36308307 Paper 36264254 Paper 36251929 Paper 36220593 Paper 36189595 Paper 36178120 Paper 36097795 Paper 36093697 Paper 36062452 Paper 36031904 Paper 36031897 Paper 36031892 Paper 35894783 Paper 35871325 Paper 35842477 Paper 35797594 Paper 35768831 Paper 35751102 Paper 35699222 Paper 35640459 Paper 35551470 Paper 35531707 Paper 35513767 Paper 35450117 Paper 35444054 Paper 35439098 Paper 35413975 Paper 35379992 Paper 35367966 Paper 35354581 Paper 35351783 Paper 35338450 Paper 35314499 Paper 35253760 Paper 35238936 Paper 35229693 Paper 35213795 Paper 35210353

Abstract

DESCRIPTION (provided by applicant): The Alzheimer Disease Research Center (ADRC) at the University of Southern California (USC) focuses on Reducing Alzheimer and Vascular Contributions to Cognitive Impairment in Diverse Populations. The ADRC views brain health in the broad context of the neurobiology and psychology of aging, with Alzheimer Disease (AD) and cerebrovascular disease (CVD) as the two major causes of pathological cognitive decline. We have built an interdisciplinary team to bridge basic science to clinical trials, well before the term "translational" research became popular. This renewal application includes three projects which strengthen translational research. Our populations include a 15-year prospective study of Caucasians enrolled in the Long Beach Longitudinal Study (LBLS), a 10-year prospective study of Hispanics in the community-based Los Angeles Latino Eye Study (LALES) and a newly funded, community-based Chinese American Eye Study (CHES). Several affiliated cohorts include the Aging Brain Program Project (PLChui) and the Progesterone and Brain Aging and Alzheimer Disease (PI: R. Brinton). During the next five years, we will focus on the following overarching goals: 1) Clarify the pathological and phenotypic interactions between AD and CVD, 2) Increase recruitment and retention of minority subjects from LALES, CHES, and the surrounding neighborhood, 3) Promote clinical trials and translational research in memory and aging at USC, and 4) Continue active participation in national initiatives, including National Alzheimer Coordinating Center (NACC), Alzheimer Disease Cooperative Study (ADCS), Alzheimer Disease Neuroimaging Initiative (ADNI), and Genome Wide Association Study (GWAS). The ADRC comprise 6 Cores (Administration, Data, Clinical, Education, Pathology, and Imaging) and 3 Projects: Zelinski (Course of Cognitive Change in Late Adulthood), Brinton/Pike (Novel NeuroSERMs and NeuroSARMs for protection against Alzheimer pathology), and Zheng (Cognitive Impairment in a Chinese American Community).

View original record on NIH RePORTER →